2013Unpublished venueRequires access

Observation on Bayaspirin combined with Simvastati in the treatment of cerebral thrombosis

Suwen Li, Danping Zheng, Minling Chen

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found. Key words: Bayaspirin;  Simvastatin;  Efficacy

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found. Key words: Bayaspirin;  Simvastatin;  Efficacy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found. Key words: Bayaspirin;  Simvastatin;  Efficacy

Key concepts: Cerebral thrombosis, Simvastatin, Medicine, Clinical efficacy, Thrombosis, Anesthesia, Placebo, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation on Bayaspirin combined with Simvastati in the treatment of cerebral thrombosis — Research Paper | ScholarLens